Skip to content

Cancer Staging

A governed assignment of an eligible cancer-related case to an extent category or stage group at a defined assessment point under cancer-specific evidence and classification rules.

Version
v1 · 2026-10-17 · History
Domain-specific #
14077
Domain group
Applied Sciences & Engineering
Origin domain
Medicine & Healthcare
Subdomain
Oncology → Medicine & Healthcare
Aliases
Oncologic staging

Core Idea

Cancer staging applies a cancer-specific rule to findings at a defined assessment point and assigns an eligible case an extent category or stage group. NCI says stage describes how far a cancer has spread and supports treatment planning, prognosis discussion, and trial consideration.[^ref-8e47bf132f89] A stage does not predict one person's outcome precisely. The rule may permit an in-situ finding: NCI identifies breast ductal carcinoma in situ (DCIS) as Stage 0.[^ref-750aec771f12]

What It Is Not

Cancer staging is not a single system used unchanged for every cancer. TNM describes primary tumor, regional nodes, and distant metastasis for many cancers,[ref-8e47bf132f89][ref-394537cc3e9e] while historical Ann Arbor grouped lymphoma extent under different criteria.[^ref-2b25765f7620] A tumor's microscopic grade is a different classification, although some breast stage groups use grade as an input.[ref-a06c25233361][ref-01e0fa63a837] NCI preserves the original diagnosis stage when the cancer later worsens.[^ref-8e47bf132f89] Later assessment should be distinguished from that stage of record.

Scope of Application

For many solid tumors, site-specific rules assign TNM component categories and may combine them into a broader stage group.[^ref-8e47bf132f89] The historical SEER Ann Arbor lymphoma variable covers diagnoses from 1983 through 2015.[^ref-2b25765f7620] NCI's current Hodgkin lymphoma summary describes Lugano as replacing original Ann Arbor in that framework.[^ref-eb0634bebdbd] NCI identifies breast DCIS as noninvasive Stage 0.[^ref-750aec771f12] This does not make every premalignant lesion stageable.

Clarity

Separate the case and scheme, the evidence and time, and the output level. Breast Tis is a tumor component.[^ref-01e0fa63a837] NCI assigns eligible breast DCIS to the complete Stage 0 group.[^ref-750aec771f12] A lymphoma Stage II and a solid-tumor Stage II cannot be equated by numeral alone. The cancer, rules, and assessment context give each label its meaning.

Manages Complexity

The staging process organizes many observations into five questions: Is the case eligible? When and how was it assessed? Which extent criteria apply? What rule maps the findings? How must the result be qualified? NCI distinguishes detailed TNM categories from broader stage groups.[^ref-8e47bf132f89] A broad group is easier to communicate, but it can compress different detailed extent patterns.

Abstract Reasoning

Start with eligibility and the governing scheme. Fix the assessment point and evidence, then apply the scheme's mapping. NCI lists Tis as a breast tumor component,[^ref-01e0fa63a837] while the historical SEER variable uses Ann Arbor lymphoma categories.[^ref-2b25765f7620] Do not treat a component as a full group or transfer one scheme's threshold into the other. Tumor grade describes microscopic cell appearance.[^ref-a06c25233361] Grade alone cannot establish a cancer-extent assignment.

Knowledge Transfer

The five questions can be asked of lymphoma and breast staging alike, although each uses its own eligibility and extent rules. Outside oncology, the questions may help compare classification methods, but kidney-function categories do not become cancer staging: KDIGO classifies chronic kidney disease by cause, filtration, and albuminuria.[^ref-d71e5f6a169c]

Examples

Historical Ann Arbor lymphoma Stage II: For a case within the historical SEER variable's scope,[^ref-2b25765f7620] two or more involved lymph-node regions on the same side of the diaphragm map to Stage II in the cited historical coding manual.[^ref-5c8ccf67b421] The case, diagnosis-year evidence, nodal extent, Ann Arbor rule, and qualified Stage II report fill the five roles. This is a rule pattern, not a patient claim or current universal lymphoma standard.

Breast DCIS Stage 0: NCI assigns eligible breast DCIS to Stage 0,[^ref-750aec771f12] with Tis available as a breast tumor component.[^ref-01e0fa63a837] The breast case, diagnostic context, in-situ finding, breast rule, and complete Stage 0 report fill the roles. Tis alone is not the full stage-group output.

Relationships to Other Abstractions

Local relationship map for Cancer StagingParents appear above the current abstraction, mutual partners to the right, and children below. Node labels state whether each abstraction is prime or domain-specific; colors identify relation types.Cancer StagingDOMAINPrime abstraction: Classification — is a kind ofClassificationPRIME

Current abstraction Cancer Staging Domain-specific

Parents (1) — more general patterns this builds on

  • Cancer Staging is a kind of Classification Prime

    Cancer staging sorts scheme-eligible cancer-related cases into qualified extent categories or stage groups by explicit evidence and assignment rules.

Hierarchy path (1) — routes to 1 parentless root

Neighborhood in Abstraction Space

Cancer Staging sits in a sparse region of the domain-specific corpus (99th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.

Family — Unclustered & Miscellaneous (2721 abstractions)

Nearest neighbors

Computed from structural-signature embeddings · 2026-10-17

References

[^ref-8e47bf132f89]: National Cancer Institute. “Cancer Staging.” https://www.cancer.gov/about-cancer/diagnosis-staging/staging . Sections “Systems That Describe Stage,” “The TNM Staging System,” and “Other Ways to Describe Stage”; stage-at-diagnosis paragraph. [^ref-a06c25233361]: National Cancer Institute. “Tumor Grade.” https://www.cancer.gov/about-cancer/diagnosis-staging/diagnosis/tumor-grade . Opening distinction between grade and stage. [^ref-750aec771f12]: National Cancer Institute. “Stages of Breast Cancer.” https://www.cancer.gov/types/breast/stages . “Stage 0 breast cancer” subsection on DCIS. [^ref-01e0fa63a837]: National Cancer Institute. “TNM Staging for Breast Cancer.” https://www.cancer.gov/types/breast/stages/tnm-staging-system . Opening stage-factor discussion and “Tumor (T), Tis” subsection. [^ref-eb0634bebdbd]: National Cancer Institute. “Hodgkin Lymphoma Treatment (PDQ®)–Health Professional Version.” https://www.cancer.gov/types/lymphoma/hp/adult-hodgkin-treatment-pdq . “Staging Subclassification System,” Lugano classification. [^ref-2b25765f7620]: National Cancer Institute SEER Program. “Lymphomas, Ann Arbor Staging.” https://seer.cancer.gov/seerstat/variables/seer/ajcc-stage/ann-arbor/ . Page heading uses a dash and a parenthetical diagnosis-year range; variable formats and historical selection criteria. [^ref-5c8ccf67b421]: National Cancer Institute SEER Program. Extent of Disease 1988: Codes and Coding Instructions, third edition, January 1998. https://seer.cancer.gov/manuals/EOD10Dig.pub.pdf . Lymphoma EXTENSION code 20, one-based PDF p. 191 / printed p. 181; historical coding evidence. [^ref-394537cc3e9e]: Union for International Cancer Control. “TNM Classification of Malignant Tumours.” https://www.uicc.org/what-we-do/sharing-knowledge/tnm . “What does TNM stand for?” and adoption rationale. [^ref-d71e5f6a169c]: KDIGO. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. https://kdigo.org/wp-content/uploads/2024/03/KDIGO-2024-CKD-Guideline.pdf . Chapter 1 and CGA classification tables; boundary comparison only.